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Abstract 
Background: The prevalence of diabetes has increased since the last decade in New Brunswick. Identifying factors 
contributing to the increase in diabetes prevalence will help inform an action plan to manage the condition. The 
objective was to describe factors that could explain the increasing prevalence of type 2 diabetes in New Brunswick 
since 2001.
Methods: A critical literature review was conducted to identify factors potentially responsible for an increase in 
prevalence of diabetes. Data from various sources were obtained to draw a repeated cross-sectional (2001–2014) 
description of these factors concurrently with changes in the prevalence of type 2 diabetes in New Brunswick. Linear 
regressions, Poisson regressions and Cochran Armitage analysis were used to describe relationships between these 
factors and time.
Results: Factors identified in the review were summarized in five categories: individual-level risk factors, environmen-
tal risk factors, evolution of the disease, detection effect and global changes. The prevalence of type 2 diabetes has 
increased by 120% between 2001 and 2014. The prevalence of obesity, hypertension, prediabetes, alcohol consump-
tion, immigration and urbanization increased during the study period and the consumption of fruits and vegetables 
decreased which could represent potential factors of the increasing prevalence of type 2 diabetes. Physical activity, 
smoking, socioeconomic status and education did not present trends that could explain the increasing prevalence 
of type 2 diabetes. During the study period, the mortality rate and the conversion rate from prediabetes to diabetes 
decreased and the incidence rate increased. Suggestion of a detection effect was also present as the number of 
people tested increased while the HbA1c and the age at detection decreased. Period and birth cohort effect were also 
noted through a rise in the prevalence of type 2 diabetes across all age groups, but greater increases were observed 
among the younger cohorts.
Conclusions: This study presents a comprehensive overview of factors potentially responsible for population level 
changes in prevalence of type 2 diabetes. Recent increases in type 2 diabetes in New Brunswick may be attributable 
to a combination of some individual-level and environmental risk factors, the detection effect, the evolution of the 
disease and global changes.
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Background
With 382 million people living with diabetes in 2013 [1], 
the World Health Organization declared the condition as 
being epidemic [2]. It is estimated that diabetes will affect 
3.7 million Canadians in 2018, making it the principal 
health challenge of the country [3]. Diabetes is associated 
with many health complications. Comparing the popula-
tion with and without diabetes, those with diabetes have a 
300% increased risk of being hospitalized [3]. Annual per 
capita healthcare costs for people with diabetes are three 
to four times greater than for individuals without diabe-
tes [3]. New Brunswick is one of the provinces in Canada 
where the prevalence of diabetes is the highest [3]. The 
prevalence of diabetes is estimated to have increased by 
86% in this province between 2000 and 2010 [4].
A population-level increase in prevalence of diabetes 
may be attributable to a wide range of potential factors 
[5–7]. Obesity is often seen as the main contributor to an 
increasing prevalence of diabetes [8–10] but other factors 
such as ageing, ethnicity, lifestyle (i.e., physical inactivity 
and energy dense diet), socioeconomic status, education, 
and urbanization have also been identified as potentially 
important factors [11–14]. Further findings also suggest 
that increasing incidence rates of diabetes [15–18] and 
global changes are other potential explanatory factors 
(e.g. environmental pollution, obesogenic environment 
and rapid socioeconomic development) that could affect 
the entire population [19, 20]. In addition to changes in 
the prevalence of risk factors, other elements, including 
increases in screening [10], changes in diagnostic criteria 
[21], and decreasing mortality rates among individuals 
with diabetes [15–18, 22–32] could contribute to the rise 
in prevalence of this condition.
Perhaps due to the wide variety of factors potentially 
responsible for an increase in prevalence of diabetes, no 
studies have attempted to present a comprehensive list 
of factors which could be responsible for population-
level changes in prevalence of diabetes. A comprehensive 
list of factors that contribute to the growing prevalence 
of diabetes would provide a foundation for population 
health planning in developing successful strategies to 
address this epidemic of diabetes. As such, the objectives 
of this study were (1) to develop a comprehensive list 
of factors to consider when trying to identify causes of 
change in prevalence of diabetes in a population and (2) 
to use this list to describe factors that may be responsible 
for the recent increase in prevalence of type 2 diabetes in 
New Brunswick.
Methods
Step 1: critical review procedure
A critical review of the literature was conducted to iden-
tify all factors potentially involved in explaining changes 
in the prevalence of diabetes. A critical review includes 
an extensive research of the literature and an evaluation 
of its quality without a systematic research approach 
[33]. This type of review includes a description of identi-
fied articles, synthesizes and analyzes the information to 
develop an hypothesis or a model for further study [33]. 
The first step of the critical review was to identify studies 
that aimed to document a wide range of factors explain-
ing changes in the prevalence of diabetes. The following 
term was used in the PubMed database to identify only 
review articles: “Review[ptyp]”. Additional terms were 
also entered at this step to identify any review articles on 
the topic of diabetes prevalence, trends, or epidemiol-
ogy: “prevalence” [title/abstract] AND “diabetes/preven-
tion and control “[majr] OR (“Diabetes” [title/abstract] 
AND “trends” [title/abstract] OR “diabetes/epidemiology 
“[majr]). The second step of the critical review searched 
studies that described other factors without restricting to 
only review articles. At this point, we used this research 
procedure “prevalence” [title/abstract] AND (“diabetes/
prevention and control “[majr]) OR (“Diabetes” [title/
abstract] AND “trends” [title/abstract]). From the 3215 
articles of the first research procedure and 1907 of the 
second, 446 were duplicates. Of the 4676 unique articles, 
we retained six review articles that presented multiple 
potential determinants of diabetes prevalence. All other 
articles were scanned to retain any articles (n = 71) which 
presented other factors not considered in the review arti-
cles identified and to provide additional empirical sup-
port to the factors identified in the reviews. In total, 77 
articles were included in this critical review.
Step 2: description of potential determinants of diabetes 
prevalence
Data sources and study population
The changes in factors potentially involved in explain-
ing an increase in a population’s prevalence of diabe-
tes identified in the critical review were studied using a 
descriptive repeated cross sectional analysis approach. 
De-identified registries of all individuals with diabetes 
and all individuals with prediabetes were created from 
New Brunswick Department of Health administrative 
datasets and were stored in a secured office within the 
New Brunswick Health Council. Those administrative 
datasets included the list of all New Brunswickers with 
provincial healthcare coverage (all Canadian residing 
in New Brunswick) and a repository of all HbA1c tests 
conducted between 2001 and 2014. Individuals were 
identified as having diabetes the first time they had a 
HbA1c test ≥6.5% (48  mmol/mol) and were excluded 
from prevalence estimates after they died based on their 
date of death. Similarly, individuals were identified as 
having prediabetes the first time they had a HbA1c test 
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between 6.0 (42  mmol/mol) and 6.4% (47  mmol/mol) 
and were removed from the prediabetes registry if they 
developed diabetes, or if they had a normal HbA1c test 
(<6.0%) (<42  mmol/mol), or if they died. Because only 
type 2 diabetes population was of interest for this study 
and because it was not possible to differentiate the type 
of diabetes in the diabetes registry, only those ≥30 years 
of age at detection were included in the analysis, with 
no maximum age limit. This approach is used by the 
New Brunswick Department of Health for their provin-
cial reports and has been used by other authors [6] since 
diabetes cases diagnosed before this age are more often 
type 1 diabetes [34]. Other data were obtained from the 
Canadian Census of Population, the Canadian Commu-
nity Health Survey, the National Household Survey, the 
Labour Force Survey and the Income Statistics Division 
from Statistics Canada. The New Brunswick databases 
used for this study were completely anonymized and the 
study was approved by the Institutional Review Board 
of the Centre hospitalier universitaire de l’Université de 
Sherbrooke.
Variables
Prevalence of diabetes and prediabetes were measured 
annually as the proportion of individuals with diabe-
tes and the proportion of individuals with prediabetes 
divided by their respective populations at risk during the 
fiscal year, defined as April 1st to March 31st. The pop-
ulation at risk was determined based on the number of 
New Brunswickers aged 30 or older recorded from the 
annual estimates of the population from Statistics Can-
ada. The denominator for incidence rates corresponded 
to the at-risk population described above minus the 
prevalent cases and incident cases during the year. Mor-
tality rate corresponded to the number of people with 
diabetes who died during the fiscal year. The denomina-
tor included all people living with diabetes, including the 
time alive among those who died within the given year. 
The conversion rate from prediabetes to diabetes was 
calculated as the number of individuals with prediabe-
tes who developed diabetes during the fiscal year over 
the number of individuals with prediabetes. Number of 
people with HbA1c testing was defined annually as the 
number of people with at least one HbA1c test during the 
fiscal year. Age at detection was derived from the date 
at which the first test attained the diagnostic threshold 
and the documented birth date of the individuals. HbA1c 
at detection was obtained by averaging the HbA1c value 
at detection of all incident cases for each fiscal year. The 
breakdown of the population by age groups was obtained 
from 2001 to 2014 from annual estimates of the entire 
New Brunswick population from Statistics Canada. The 
prevalence of select risk factors was determined from 
self-reported information available for the New Brun-
swick population from the Canadian Community Health 
Survey in 2003, 2005 and annually from 2007 to 2014 for 
people aged 35  years old and greater. These risk factors 
included obesity (body mass index ≥30, calculated from 
self-reported height and weight data), hypertension (self-
reported diagnosis received from a healthcare profes-
sional), consumption of fruits and vegetables (eating fruits 
and vegetables usually more than five times per day), 
physical activity (categorized as active or inactive based 
on the average daily physical activity reported for the 3 
previous months), alcohol consumption (having drunk 
more than five glasses of alcohol at one occasion, at least 
once a month during the last year—note that because 
of changes in definitions in 2013, only data up to 2012 
were considered herein) and smoking (smoking cigarettes 
every day). Level of education (number of people who 
completed high school; number with a university degree) 
was obtained from the Labour Force Survey from 2001 to 
2014. Socioeconomic status (percentage of people having 
low income before taxes) was available from 2001 to 2011 
from the Income Statistics Division of Statistics Canada 
and urbanization (people living in a rural area, defined as 
any territory situated outside population centers which 
contain a population of at least 1000 person and a density 
of 400 or more person by square kilometer) was obtained 
from Census data for 2001, 2006 and 2011. Ethnicity 
(percentage of immigration used as a proxy for ethnicity 
herein) was also obtained from Census data for 2001 and 
2006 and from the National Household Survey for 2011.
Statistical analysis
Cochran–armitage analyses of trend were used to assess 
the association between time (fiscal year) and variables 
represented as yearly prevalence. Poisson regressions 
were used to assess associations between time and mor-
tality rate and between time and conversion rate from 
prediabetes to diabetes. Linear regressions were used to 
assess time trends in number of people who undergone 
HbA1c testing, the average value of HbA1c and the aver-
age age at detection. Assessing the presence of a period 
effect was done by calculating the prevalence of diabetes 
across 10 year age groups (30–39, …, 90+) for each fiscal 
year. Assessing for the presence of a birth cohort effect 
was also done by calculating the prevalence of diabetes 
among decade-of-birth-based cohorts (1910–1920, …, 
1961–1970) for each fiscal year.
Results
From 101,519 individuals identified with diabetes in the 
registry between 2001 and 2014, 97,865 individuals were 
included because they were diagnosed at 30 years old or 
older. The prevalence of type 2 diabetes increased by an 
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average of 6.4% per year over this time period, which rep-
resents an overall increase of 120% (Table  1). The criti-
cal literature review identified several factors that could 
potentially explain such a change in the prevalence of 
diabetes at a population level. The factors have been 
grouped in five categories (Table  2) which are defined 
below. A description of these factors from 2001 to 2014 
in New Brunswick is also presented to better understand 
how they could have contributed to the rise in prevalence 
of diabetes in this region. In Table 2, factors for which we 
found information and which we included in the analyses 
are presented in italics.
Individual‑level risk factors
According to the literature review, the rise in a popu-
lation’s prevalence of diabetes could be attributed to 
increases in that population’s prevalence of individual-
level risk factors for the condition. Concurrently, we 
noted a marked increase in the prevalence of prediabetes 
from 2001 to 2014 (Table  1). Increases were also noted 
in the prevalence of obesity, hypertension, alcohol con-
sumption, and immigration over the same period of time. 
During the study period, we also found the population 
was aging and that the prevalence of consumption of 
fruits and vegetables decreased.
However, the proportion of people reporting a physi-
cally active lifestyle, sedentary behaviours, tobacco 
smoking, having completed high school and university 
education, and being of low income evolved in directions 
that were opposite to the direction expected to be con-
sidered as a factor contributing to the increasing preva-
lence of diabetes.
Environmental risk factors
The literature review has shown that some environmental 
risk factors such as the presence of environmental pollut-
ants (such as nitrogen dioxide (NO2), particulate matter 
(PM), organic persistent pollutants and non-persistent 
pesticides), urbanization and rapid socioeconomic devel-
opment could explain part of the increase in the preva-
lence of diabetes. In this study, the only factor that was 
possible to measure was the urbanization based on the 
proportion of people living in a rural area. This propor-
tion decreased during the study period and evolved in 
a direction supporting that it may have influenced the 
increase in prevalence of diabetes in New Brunswick 
(Table 1).
Evolution of the disease
Some factors characterizing the evolution of the disease, 
including survival time among individuals with diabe-
tes, number of new cases of diabetes and conversion to 
diabetes from prediabetes population, could explain the 
increase in the prevalence of diabetes. In this study, we 
found that only two of these factors evolved in the direc-
tion expected if these factors were to explain the increase 
in prevalence of diabetes. The incidence rate increased 
from 2001 to 2014 and a higher increase in the incidence 
rate was seen around 2002 and 2005 (Table 1). The mor-
tality rate of the population with diabetes decreased in 
the same period. In contrast, the conversion rate from 
prediabetes to diabetes could not explain the increase in 
prevalence of diabetes because it decreased during this 
period.
Detection effect
The literature review also suggested that a change in 
prevalence of disease could be attributed to changes in 
how the condition is identified. The detection effect could 
be related to an increase in the number of people being 
screened or diagnosed, an earlier detection of the disease 
and changes in diagnostic criteria. Accordingly we found 
that the number of people tested for HbA1c increased 
from 2001 to 2014 and showed a higher increase around 
2003 and 2010 (Fig. 1). Concurrently, the mean HbA1c at 
detection decreased between 2001 and 2014 suggesting 
that people are being diagnosed earlier in the evolution 
of the disease (Table  1). It was also noted that the per-
centage of individuals with diabetes previously identified 
with prediabetes increased from 2001 to 2014, also sug-
gesting that people are being detected at an earlier stage 
of their disease. The average age at detection also sup-
ports the presence of a detection effect since data suggest 
that people are being diagnosed at a younger age.
Global changes
Changes in any or a combination of factors above may 
affect all of the population regardless of people’s age 
(period effect). Changes in factors could also be more 
pronounced in segments of the population, based on the 
year of birth (birth cohort effect). In this study, the pres-
ence of a period effect was supported by an increase in 
the prevalence of type 2 diabetes from 2001 and 2014 in 
each age group, with the 40–49 year old age group dis-
playing a greater increase (Fig.  2a). The presence of a 
birth cohort effect was also suggested since the increase 
in prevalence of type 2 diabetes was considerably greater 
among the youngest birth cohort compared to the oldest 
birth cohorts (Fig. 2b).
Discussion
The prevalence of type 2 diabetes has more than dou-
bled in the past 15  years in New Brunswick. Although 
this prevalence change is relatively greater than changes 
noted elsewhere, this is consistent with the increase in 
prevalence in diabetes observed in recent years in other 
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provinces and countries around the world [69, 72]. To 
help identify factors responsible for this increase, our 
literature review led to the identification of five catego-
ries of factors which together represent a comprehensive 
overview of factors that could explain a change in preva-
lence of diabetes. Our review included considerably more 
potential factors than what had been reported in other 
literature reviews [5–7, 35, 57, 73]. Guided by this inven-
tory, we assessed the changes in nearly all factors sug-
gested to potentially influence the prevalence of diabetes 
in New Brunswick. Through this work, we identified that 
changes in prevalence of diabetes in New Brunswick are 
likely attributed to a combination of numerous factors.
Among individual-level risk factors identified in the 
critical review, our analysis suggests that the presence 
of other conditions, such as the aging population, obe-
sity, hypertension and prediabetes could contribute to 
explain the increase in prevalence of type 2 diabetes in 
New Brunswick. Furthermore, although immigration 
increased in NB, it is difficult to conclude that ethnicity 
might have an effect on the prevalence of type 2 diabetes 
in NB since no information is available on ethnic origin 
of immigrants in the databases used.
An increase in prevalence of obesity or body mass 
index has been linked to increases in the prevalence 
of diabetes in many other studies [8, 37–39, 68] and 
authors suggested it is the most important contributor 
to increases in prevalence of diabetes [8–10]. Consist-
ent with changes in body composition of the population, 
we also noted that diet quality decreased over the study 
period. However, our data suggest that New Brunswick-
ers became more physically active in the past 15  years, 
which does not concord with trends for obesity and dia-
betes. It has been suggested that this discrepancy may 
be attributable to measurement error associated with 
the use of self-reported measures [74]. Self-reported 
measures, such as physical activity levels, are suspected 
to have been influenced by an increase in social desir-
ability possibly creating higher estimates over the years 
[74]. However, our results are consistent with the appar-
ent increase in prevalence of a physically active lifestyle 
in the United States from 2001 and 2009, which seems 
to have had minimal impact on reducing the burden of 
obesity [75]. Among the potential for environmental risk 
factors to have influenced diabetes, we only had access to 
data relating to urbanization and these suggested that the 
transition from a predominantly rural to an urban popu-
lation accompanied the increase in prevalence of diabe-
tes in New Brunswick. This transition may mean that a 
greater proportion of the population may be exposed 
to obesogenic environments such as more sedentary 
work, higher use of car and public transport, television 
viewing and in short, lower levels of physical activity 
[6]. Although environmental pollution can be present 
in rural regions, it is also possible that urbanization has 
led to more exposure to pollutants. A meta-analysis has 
shown that the prolonged exposition to nitrogen dioxide 
(NO2), particulate matter less than 2.5 mm (PM2.5), and 
particulate matter less than 10 micrometers (PM10) was 
associated to type 2 diabetes incidence in cohort studies 
[55].
Table 2 Factors potentially involved in explaining changes in a population’s prevalence of diabetes
Categories of factors Factors potentially involved
Individual-level risk factors Age [5, 35–40], obesity [7–11, 13, 35–41], ethnicity [35, 42, 43], chronic disease (hypertension [44, 45], high triglycerides [44, 
45], prediabetes [35, 46]), lifestyle (eating behavior [5, 6, 12, 14, 47], physical activity [5–7, 12, 14], smoking [5, 12, 13, 48], 
excessive alcohol consumption [14, 49, 50]), socio economic status [5, 51], low education [43, 51, 52], gestionnal diabetes 
[7, 35], intra uterin environnment [35], nutritional transition status [7] and diabetes familial history [5]
Environmental risk factors Urbanization [5, 6, 12, 44, 53] environnmental pollution [35, 54–56] and rapid socioeconomic development [35]
Evolution of the disease Increasing incidence rate [15, 17, 18, 23, 26, 27, 30, 32, 43, 57–63] decreasing mortality rate [15, 16, 18, 22–31, 64] and 
increasing conversion rate from prediabetes to diabetes [65]
Detection effect Increase in number of people screened [22, 66] or diagnosed [57, 67] and decrease in people undiagnosed [9, 10, 57, 68, 
69] or not screened [22], decreasing age at detection [36, 58, 70, 71] or increase in the prevalence of diabetes at earlier 
age [35, 45, 71], decreasing HbA1c mean at detection and change in diagnostic criteria [35]
Global changes Period effect [19] and birth cohort effect [19, 20]
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Changes in how diabetes evolves may also contribute 
to explaining a change in how the prevalence of disease 
increased in New Brunswick. Most particularly, we noted 
a decline in mortality rates of people with diabetes from 
2001 to 2014, which is consistent with results from other 
studies [18, 22, 23, 26–28, 31]. The 40% decrease in mor-
tality rates observed in our study over 14 years is similar 
to the 37.2% decrease in mortality witnessed in Ontario 
between 1996 and 2009 [29]. A longer survival period in 
the population with diabetes, likely explained by better 
treatment and control of the disease [48], therefore con-
tributed to the increase in prevalence. An increase in the 
conversion rate from prediabetes to diabetes could also 
have explained an increase in diabetes prevalence [65]. 
However, this study shows a decrease in the conversion 
rate from prediabetes to diabetes, therefore suggesting 
either better prevention efforts in this population at risk 
or a relatively higher proportion of people identified with 
prediabetes through more screening.
As our data indicated, it is highly probable that part 
of the increase in prevalence of diabetes can be attrib-
uted to a detection effect whereby the number of people 
tested with HbA1c rose markedly during the study period. 
Although the increase in testing was observed every year, 
sharper increases appeared to coincide with milestones 
such as the publication of the 2003 and 2008 guidelines 
encouraging type 2 diabetes screening [76, 77] and the 
identification of HbA1c as a recognised diagnostic tool 
by the American Diabetes Association in 2010 [78]. The 
possibility of earlier detection of the disease is also sup-
ported by a decrease in HbA1c levels and age at detection 
during the study period. The increase in testing and an 
early detection may also partly be explained by the study 
period corresponding with the introduction of financial 
incentives for physicians to offer recommended care to 
their patients with diabetes (2010), the implementation 
of an HbA1c tracking tool created to improve adher-
ence to guidelines (2009) [79] and the Physician Practice 
profiles implemented in 2010 to aid physicians to iden-
tify at risk patients in New Brunswick. It should also be 
mentioned that although our analysis did not allow for 
the assessment of the relative contribution of each factor, 
another study suggested that improvements in detection 
of diabetes could explain as much as 25% of the increase 
in the prevalence of diabetes diagnosed since 1970 [10].
The fact that an increase in the prevalence of type 2 
diabetes was observed in all age groups over the 15 years 
of study supports the presence of a period effect. The 
percentage of change in the prevalence of diabetes was 
nevertheless higher among the 40–49  years old, as it is 
possible that this group benefited from a higher detec-
tion effect than other age groups. The period effect could 
be attributed to a combination of any of the other factors 
identified in this study, including urbanization, increases 
in immigration and an increase in the detection. Other 
factors not measured, such as rapid socioeconomic devel-
opment and increase in environmental pollution, could 
also be at play [19]. The data also presented evidence of 
a birth cohort effect as we observed higher increases in 
the prevalence of type 2 diabetes in the younger cohort 
groups. This could be explained by exposure early in life 
to some environmental factors related to an increase in 
obesity, as suggested by Soon et al. [19]. These results are 
consistent with others who demonstrated that steeper 
increases in the prevalence of diabetes in the youngest 
cohort parallel increases in the prevalence of obesity in 
the younger generations [19, 20]. The development of 
more obesogenic environment may affect younger peo-
ple to a greater extent than other age groups since it 
represents a great proportion of their relative environ-
mental exposure [19]. Further, another study reported 
that weight gain between 25 and 40 years old was asso-
ciated with a higher risk of diabetes than a weight gain 
after 40 years old [80].
The present study has some limitations that need to be 
acknowledged. First, because of the descriptive design of 
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the study, it was not possible to quantify and contrast the 
relative contribution of each factor. Second, the preva-
lence of diabetes and prediabetes could be underestimated 
due to the use of only one diagnostic method (HbA1c test) 
in determining presence of disease and because HbA1c 
was only endorsed as a diagnostic method after 2010. 
However, because the HbA1c test had been in significant 
use prior to 2010 for the management of the disease [81], 
we hypothesise that most of the time a diagnosis of dia-
betes was followed by a HbA1c test a short period after. In 
the same way, the detection effect measured in part by the 
number of people tested with a HbA1c could be overes-
timated by the fact that the HbA1c values for prediabetes 
or diabetes screening had not been identified before 2010 
and we did not consider other screening tests such as fast-
ing glucose and oral glucose tolerance test which were 
often used before 2010. However, HbA1c test has differ-
ent sensitivity, specificity and utility than other diagnostic 
tests such as OGTT and fasting glucose [35] and because 
of that, it is advisable to use the same diagnostic test over 
time. Also, even though the HbA1c test is not universally 
accepted as a diagnostic tool [82] and may be affected by 
some individual conditions [83], it represents less indi-
vidual variability than other tests and provides a better 
reflection of the glucose homeostasis in the long term 
[84]. Third, because it was not possible to distinguish the 
type of diabetes in the diabetes registry, it was not possi-
ble to exclude gestational diabetes cases and type 1 diabe-
tes was excluded only on the basis of age. However, the 4% 
exclusion of potential type 1 diabetes individuals is close 
to the proportion of type 1 diabetes which is estimated to 
represent about 5-10% of cases of diabetes [85]. Fourth, it 
was not possible to measure some risk factors because of 
lack of data available, including gestational diabetes, intra 
uterin environnment, nutritional transition status, family 
diabetes history, environmental pollution, rapid socio-
economic development and high triglycerides. Fifth, our 
description of risk factors was performed concurrently to 
the change in prevalence of diabetes we were attempting 
to explain. Since diabetes has a long latency period, it may 
be appropriate to start describing those factors before 
2001. This study also has strengths that need to be high-
lighted. This is the first study that describes an overview 
of factors that could explain the increase in prevalence of 
type 2 diabetes and used a population based analysis to 
measure almost all of those factors. The majority of analy-
sis was done on the entire New Brunswick population and 
almost all the data was available for the 15 year period.
Conclusions
In conclusion, this study presents a comprehensive over-
view of potential factors that could explain the change in 
the prevalence of type 2 diabetes. This study shows that for 
the past 15 years, the prevalence of diabetes in New Brun-
swick has increased considerably and this increase could 
be explained by many factors including some individual-
level and environmental risk factors, the detection effect, 
the evolution of the disease and global changes. However, 
the increasing prevalence of diabetes observed may not 
be as impressive as it appears due to the significant influ-
ence of the detection effect and the dramatic decrease in 
mortality. A better understanding of factors potentially 
responsible for the increase in type 2 diabetes can assist 
in making informed decisions about diabetes programs 
and policies. This study may be used as a template for 
other countries or provinces to identify factors that could 
explain the increase in the prevalence of diabetes in their 
respective jurisdictions. More research is needed to meas-
ure the relative contribution of each factor on the increase 
in prevalence of diabetes by measuring each factor directly 
at the individual level and to evaluate the change in risk 
factors earlier in the evolution of the disease.
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